POSACONAZOLE AS PRIMARY PROPHYLAXIS REDUCES INVASIVE FUNGAL INFECTIONS IN AML PATIENTS: A SINGLE CENTRE MATCHED PAIRED ANALYSIS

被引:0
|
作者
Minetto, P. [1 ]
Guolo, F. [1 ]
Pastori, G. [1 ]
Giannoni, L. [1 ]
Guardo, D. [1 ]
Avenoso, D. [1 ]
Clavio, M. [1 ]
Miglino, M. [1 ]
Lemoli, R. M. [1 ]
Gobbi, M. [1 ]
机构
[1] Univ Genoa, Chair Hematol, Dept Internal Med DiMI, IRCSS AOU San Martino IST, Genoa, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1813
引用
收藏
页码:717 / 718
页数:2
相关论文
共 50 条
  • [31] Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment
    Hachem, R. Y.
    Langston, A. A.
    Graybill, J. R.
    Perfect, J. R.
    Pedicone, L. D.
    Patino, H.
    Raad, I. I.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1386 - 1391
  • [32] Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients
    Lellek, Heinrich
    Waldenmaier, Dirk
    Dahlke, Joachim
    Ayuk, Francis Ayketang
    Wolschke, Christine
    Kroeger, Nicolaus
    Zander, Axel R.
    MYCOSES, 2011, 54 : 39 - 44
  • [33] Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
    Almutairy, Reem
    Khan, Mansoor Ahmed
    Shahbar, Alaa
    Aseeri, Mohammed
    Alshamrani, Majed
    Almarhabi, Hassan
    Naeem, Doaa
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [34] Posaconazole prophylaxis - impact on incidence of invasive fungal disease and antifungal treatment in haematological patients
    Peterson, Lisa
    Ostermann, Julia
    Rieger, Heidi
    Ostermann, Helmut
    Rieger, Christina Theresa
    MYCOSES, 2013, 56 (06) : 651 - 658
  • [35] Mortality rates for breakthrough invasive fungal infections in a multicenter trial of posaconazole vs standard azole prophylaxis
    Winston, D. J.
    Cornely, O. A.
    Maertens, J.
    Perfect, J.
    Helfgott, D. D.
    Ullmann, A. J.
    Holowiecki, J.
    Stockelberg, D.
    Goh, Y-T.
    Petrini, M.
    Walsh, T. J.
    Hardalo, C.
    Angulo-Gonzalez, D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S64 - S65
  • [36] Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review
    Boutin, Catherine-Audrey
    Durocher, Florence
    Beauchemin, Stephanie
    Ziegler, Daniela
    Abou Chakra, Claire Nour
    Dufresne, Simon Frederic
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (01) : 151 - 160
  • [37] Lack of Evidence for Exposure-Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections
    Cornely, O. A.
    Ullmann, A. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 351 - 352
  • [38] Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study
    Liu, Yan
    Qu, Ruochen
    Zhao, Yan
    Wang, Ziyi
    Yuan, Shizhao
    Liu, Shuai
    Zhou, Chunhua
    Yu, Jing
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2025, 47 (02) : 382 - 391
  • [39] Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy
    Wong, Gee-Chuan
    Halim, Nurul Aidah Abdul
    Tan, Ban-Hock
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) : 1351 - U150
  • [40] Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients A retrospective observational study
    Chen, Xiaochen
    Wang, Jianxiang
    Wang, Sanbin
    Jin, Jie
    Li, Junmin
    Gao, Sujun
    Li, Jianyong
    Li, Juan
    Liu, Qifa
    Hu, Yu
    Lin, Dongjun
    Sun, Zimin
    Yang, Jianmin
    Hu, Jianda
    Wu, Xiaoxiong
    Huang, Xiaojun
    Shao, Zonghong
    Deng, Qi
    Wang, Chun
    Liu, Li
    Chen, Hu
    Wang, Jingbo
    Wei, Xudong
    Shen, Jianping
    Zhang, Xi
    Wu, Depei
    MEDICINE, 2021, 100 (30) : E26772